Skip to the main content.

Outcome-Driven Solutions for Medtech Challenges

Breakthrough innovation requires more than great solutions; it demands deep expertise and insight. Veranex packages outcome-driven solutions with 25+ years of specialized knowledge across major medtech categories, delivering integrated capabilities that solve your most pressing challenges faster and with greater certainty.

Purpose-built solutions. Proven results. User & Patient-centered innovation.

 

Purpose-Built for Breakthroughs

Whether you're transforming patient care or disrupting entire therapeutic categories, innovation requires more than great science, it demands velocity.  Veranex was founded to bridge the gap between visionary concepts and market reality, combining proven expertise with agile execution to accelerate the innovations that matter most.  

We are the Innovation CRO.

Legacy of excellence. Proven execution. Patient impact accelerated.

 

Tim Shefflin

Tim Sheflin is our vice president of commercial strategy and market access. Tim has over 20 years of consulting experience assessing the reimbursement environment for medical devices, in vitro diagnostics, specialty drugs and biologics. His work addresses the private and public payer product evaluation processes, as well as coverage policies and formulary analyses. Tim is an expert at the design, conduct, and analysis of payer research that produces insightful and actionable strategies. He also designs tactical reimbursement launch plans and needs assessments for specialty drug companies whose products require physician reimbursement support services and payer accounts management. In addition, he has developed strategies for novel diagnostic imaging modalities used for detection, treatment planning, and surveillance. He holds a BA in Political Science from Connecticut College.